{
  "source": "PubMed",
  "query": "secondary metabolites",
  "title": "4-O-Demethylbarbatic acid has a novel therapeutic impact on the progression of EGFR-driven lung adenocarcinoma.",
  "abstract": "4-O-Demethylbarbatic acid (4O-DBA), a secondary metabolite derived from lichen species, has shown inhibitory activity of epstein-barr virus (EBV), indicating its potential in cancer prevention or treatment. However, the mechanisms underlying its anti-cancer effects, particularly in non-small cell lung cancer (NSCLC), remain unclear.",
  "publication_date": "2025-06-11",
  "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
  "doi": "10.1016/j.phymed.2025.156973"
}